You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞麗醫美(02135.HK)上半年轉虧為盈至148.2萬元
格隆匯 08-26 20:18

格隆匯8月26日丨瑞麗醫美(02135.HK)公佈,截至2022年6月30日止六個月,集團實現收益9439.7萬元人民幣(單位下同),同比增長3.18%;毛利為4437.5萬元,同比增長19.62%;母公司擁有人應占盈利為148.2萬元,上年同期為虧損為523.7萬元;每股基本虧損為0.07分。

於報吿期內,儘管公司的銷售業績繼續受到疫情的各種不利影響,但由於公司的醫療美容服務業務分部業績持續得以改善、匯兑差額的積極影響,加之集團新推出醫療美容器械產品的銷售及尤其嚴格控制銷售、推廣及營銷開支等成本,實現了上半年的利潤轉虧為盈。然而,長三角地區醫療機構均受中國上海地區疫情的不利影響,經營情況依然悲觀。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account